Single intravitreal ranibizumab for myopic choroidal neovascularization

Saidin Nor-Masniwati, Ismail Shatriah, Embong ZunainaDepartment of Ophthalmology, Universiti Sains Malaysia, Kelantan, MalaysiaAbstract: We report a case of myopic choroidal neovascularization that showed improvement after a single injection of ranibizumab. A 45-year-old Chinese man with high myopia...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shatriah I, Nor-Masniwati S, Zunaina E
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/8dfcc821f4b54f369c1fd6f45903fa64
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8dfcc821f4b54f369c1fd6f45903fa64
record_format	dspace
spelling	oai:doaj.org-article:8dfcc821f4b54f369c1fd6f45903fa642021-12-02T05:12:09ZSingle intravitreal ranibizumab for myopic choroidal neovascularization1177-54671177-5483https://doaj.org/article/8dfcc821f4b54f369c1fd6f45903fa642011-08-01T00:00:00Zhttp://www.dovepress.com/single-intravitreal-ranibizumab-for-myopic-choroidal-neovascularizatio-a8018https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Saidin Nor-Masniwati, Ismail Shatriah, Embong ZunainaDepartment of Ophthalmology, Universiti Sains Malaysia, Kelantan, MalaysiaAbstract: We report a case of myopic choroidal neovascularization that showed improvement after a single injection of ranibizumab. A 45-year-old Chinese man with high myopia presented with sudden onset painless central scotoma of his right eye of 2 weeks&rsquo; duration. There was no history of trauma. His right eye vision on presentation was 6/30 which showed no improvement with pinhole. The right fundus showed myopic maculopathy at the posterior pole with subretinal hemorrhage at the inferotemporal fovea. The optic disc was tilted with inferotemporal peripapillary atrophy. There was a myopic maculopathy appearance in the macula of the left eye. Fundus fluorescein angiography revealed choroidal neovascularization at the fovea of the right eye. A diagnosis of right eye choroidal neovascularization secondary to myopic maculopathy was made. A single intravitreal injection of ranibizumab 0.05 mL was given. Ten weeks following intravitreal injection, vision had improved to 6/7.5, and repeated fundus fluorescein angiography showed absence of choroidal neovascularization. Follow-up at 6 months showed visual acuity had normalized to 6/6 with glasses, which was maintained up to 12 months following treatment. The right fundus showed no further subretinal hemorrhage with no new lesions.Keywords: myopia, choroidal neovascularization, antivascular endothelial growth factorShatriah INor-Masniwati SZunaina EDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 1079-1082 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Shatriah I Nor-Masniwati S Zunaina E Single intravitreal ranibizumab for myopic choroidal neovascularization
description	Saidin Nor-Masniwati, Ismail Shatriah, Embong ZunainaDepartment of Ophthalmology, Universiti Sains Malaysia, Kelantan, MalaysiaAbstract: We report a case of myopic choroidal neovascularization that showed improvement after a single injection of ranibizumab. A 45-year-old Chinese man with high myopia presented with sudden onset painless central scotoma of his right eye of 2 weeks&rsquo; duration. There was no history of trauma. His right eye vision on presentation was 6/30 which showed no improvement with pinhole. The right fundus showed myopic maculopathy at the posterior pole with subretinal hemorrhage at the inferotemporal fovea. The optic disc was tilted with inferotemporal peripapillary atrophy. There was a myopic maculopathy appearance in the macula of the left eye. Fundus fluorescein angiography revealed choroidal neovascularization at the fovea of the right eye. A diagnosis of right eye choroidal neovascularization secondary to myopic maculopathy was made. A single intravitreal injection of ranibizumab 0.05 mL was given. Ten weeks following intravitreal injection, vision had improved to 6/7.5, and repeated fundus fluorescein angiography showed absence of choroidal neovascularization. Follow-up at 6 months showed visual acuity had normalized to 6/6 with glasses, which was maintained up to 12 months following treatment. The right fundus showed no further subretinal hemorrhage with no new lesions.Keywords: myopia, choroidal neovascularization, antivascular endothelial growth factor
format	article
author	Shatriah I Nor-Masniwati S Zunaina E
author_facet	Shatriah I Nor-Masniwati S Zunaina E
author_sort	Shatriah I
title	Single intravitreal ranibizumab for myopic choroidal neovascularization
title_short	Single intravitreal ranibizumab for myopic choroidal neovascularization
title_full	Single intravitreal ranibizumab for myopic choroidal neovascularization
title_fullStr	Single intravitreal ranibizumab for myopic choroidal neovascularization
title_full_unstemmed	Single intravitreal ranibizumab for myopic choroidal neovascularization
title_sort	single intravitreal ranibizumab for myopic choroidal neovascularization
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/8dfcc821f4b54f369c1fd6f45903fa64
work_keys_str_mv	AT shatriahi singleintravitrealranibizumabformyopicchoroidalneovascularization AT normasniwatis singleintravitrealranibizumabformyopicchoroidalneovascularization AT zunainae singleintravitrealranibizumabformyopicchoroidalneovascularization
_version_	1718400542579884032

Single intravitreal ranibizumab for myopic choroidal neovascularization

Ejemplares similares